Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Transfusion

• Publication date

  2014-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/trf.12217PMID 23621760PMCID PMC3732531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion

  2013cited by this paper
• Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells

  2012cited by this paper
• Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

  2012cited by this paper
• Management and Prevention of Red Cell Alloimmunization in Pregnancy: A Systematic Review

  2012cited by this paper
• Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcγ receptors in a murine model

  2012cited by this paper
• Use of mouse models to study the mechanisms and consequences of RBC clearance

  2010cited by this paper
• Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models?

  2009cited by this paper
• IMMUNOHEMATOLOGY: Storage of murine red blood cells enhances alloantibody responses to an erythroid‐specific model antigen

  2009cited by this paper
• Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice.

  2009cited by this paper
• Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model.

  2009cited by this paper
• The persistence and evanescence of blood group alloantibodies in men

  2009cited by this paper
• An autoanti‐Kpb immunoglobulin M that simulates antigen suppression

  2009cited by this paper
• Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions.

  2008cited by this paper
• Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans

  2008cited by this paper
• Fetal anemia due to non-Rhesus-D red-cell alloimmunization.

  2008cited by this paper
• The role of inflammation in alloimmunization to antigens on transfused red blood cells

  2008cited by this paper
• Discrete Toll‐like receptor agonists have differential effects on alloimmunization to transfused red blood cells

  2008cited by this paper
• Lessons learned from mouse models of hemolytic transfusion reactions

  2008cited by this paper
• Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.

  2007cited by this paper
• Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

  2007cited by this paper
• Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes.

  2007cited by this paper
• Mouse models of IgG- and IgM-mediated hemolysis.

  2007cited by this paper
• Management of Kell isoimmunization — evaluation of a Doppler‐guided approach

  2006cited by this paper
• On the immunologic basis of Rh immune globulin (anti‐D) prophylaxis

  2006cited by this paper
• Update on HDFN: new information on long-standing controversies

  2006cited by this paper
• Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells

  2006cited by this paper
• The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb‐expressing mice

  2006cited by this paper
• On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.

  2006cited by this paper
• Nonhemolytic antibody-induced loss of erythrocyte surface antigen.

  2005cited by this paper
• Red blood cell blood group antigens: structure and function.

  2004cited by this paper
• Review: the Kell, Duffy, and Kidd blood group systems

  2004cited by this paper
• Monoclonal anti-D development programme.

  2002cited by this paper
• The Danger Model: A Renewed Sense of Self

  2002cited by this paper
• Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice.

  2001cited by this paper
• The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function

  2000cited by this paper
• Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.

  1998cited by this paper
• The Blood Group Antigen Factsbook

  1997cited by this paper
• Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells

  1997cited by this paper
• Maternal Kell blood group alloimmunization

  1992cited by this paper
• What is a blood group antigen?

  1992cited by this paper
• Anti‐Kell in pregnancy

  1991cited by this paper
• Anti‐Kell in Pregnancy

  1991cited by this paper
• Prp (proline-rich protein) genes linked to markers Es-12 (esterase-12), Ea-10 (erythrocyte alloantigen), and loci on distal mouse chromosome 6.

  1989cited by this paper
• Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity

  1983cited by this paper
• Auto‐Anti‐Kpb Associated with Weakened Antigenicity in the Kell Blood Group System: A Second Example

  1979cited by this paper
• H‐5.A AND H‐6.A, TWO MOUSE ISOANTIGENS ON RED CELLS AND TISSUES DETECTED SEROLOGICALLY1

  1963cited by this paper
• Fatal transfusion reaction due to the Kell factor.

  1953cited by this paper
• In-vivo isosensitisation of red cells in babies with haemolytic disease.

  1946cited by this paper

• Analysis of irregular antibodies in patients receiving multiple transfusions of packed red cell products: a cross-sectional study

  2026cites this paper
• Large‐Scale Production of Transfusion‐Ready Red Blood Cells From Induced Pluripotent Stem Cells

  2025cites this paper
• Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice

  2024cites this paper
• Dynamics of antibody engagement of red blood cells in vivo and in vitro

  2024cites this paper
• Harnessing the potential of red blood cells in immunotherapy.

  2024cites this paper
• Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody‐mediated immune suppression or enhancement in a murine model

  2023cites this paper
• The Growing Challenge of RBC Alloimmunization in the Management of Patients with Sickle Cell Disease.

  2023cites this paper
• Antibody-Mediated Antigen Loss Switches Augmented Immunity to Antibody-Mediated Immunosuppression.

  2023cites this paper
• Antigen‐specific IgG subclass composition in recipient mice can indicate the degree of red blood cell alloimmunization as well as discern between primary and secondary immunization

  2023cites this paper
• The Development and Consequences of Red Blood Cell Alloimmunization

  2022cites this paper
• Alloantigen Copy Number as a Critical Factor in RBC Alloimmunization.

  2022cites this paper
• The role of RBC antigen transgene integration sites on RBC biology in mice

  2022cites this paper
• Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice

  2022cites this paper
• Antibodies to Low-Copy Number RBC Alloantigen Convert a Tolerogenic Stimulus to an Immunogenic Stimulus in Mice

  2021influential citation
• Marginal Zone B Cells Mediate a CD4 T Cell Dependent Extrafollicular Antibody Response Following RBC Transfusion in Mice.

  2021cites this paper
• Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.

  2021cites this paper
• Alloimmunization in Pregnancy

  2020cites this paper
• Poly (I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.

  2020cites this paper
• Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation

  2020influential citation
• IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice

  2020cites this paper
• Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model

  2020cites this paper
• Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction

  2020cites this paper
• Type 1 IFN signaling critically regulates influenza‐induced alloimmunization to transfused KEL RBCs in a murine model

  2019cites this paper
• Large-scale in-vitro production of red blood cells from human peripheral blood mononuclear cells

  2019cites this paper
• Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.

  2019cites this paper
• Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.

  2019cites this paper
• Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses.

  2018cites this paper
• Methods for blood group antigens detection: cost-effectiveness analysis of phenotyping and genotyping

  2018cites this paper
• Red blood cell alloimmunisation: induction of immunity and potential mitigation strategies

  2018cites this paper
• Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion

  2018cites this paper
• Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

  2018cites this paper
• Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen

  2018cites this paper
• Antibody-mediated immune suppression by antigen modulation is antigen-specific.

  2018cites this paper
• B cells require Type 1 interferon to produce alloantibodies to transfused KEL‐expressing red blood cells in mice

  2017cites this paper
• Anti-CD20 Antibody Prevents Red Blood Cell Alloimmunization in a Mouse Model

  2017cites this paper
• Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice

  2017influential citation
• Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia

  2017cites this paper
• The impact of vaccination on RBC alloimmunization in a murine model

  2017cites this paper
• This information is current as Alloimmunization in Mice Inflammation-Induced Red Blood Cell Type I IFN Is Necessary and Sufficient for

  2017influential citation
• This information is current as Alloimmunization in a Mouse Model Anti-CD 20 Antibody Prevents Red Blood Cell

  2017cites this paper
• Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series

  2016cites this paper
• Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.

  2016cites this paper
• Gaps in Research on Adverse Events to Transfusion in Pediatrics.

  2016cites this paper
• Understanding red blood cell alloimmunization triggers.

  2016cites this paper
• Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice.

  2016cites this paper
• Immune responses to red blood cell antigens

  2016cites this paper
• Clinically significant anti‐KEL RBC alloantibodies are transferred by breast milk in a murine model

  2016cites this paper
• Silencing and overexpression of human blood group antigens in transfusion: Paving the way for the next steps.

  2015cites this paper
• Generation of mice expressing human RHAG and RHD blood group genes

  2015cites this paper
• Pathobiology of transfusion reactions.

  2015cites this paper
• Innate immunity against molecular mimicry: Examining galectin‐mediated antimicrobial activity

  2015cites this paper
• Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model

  2015cites this paper
• Red blood cell alloimmunization mitigation strategies.

  2014cites this paper
• The RBC as a Target of Damage

  2014cites this paper
• Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models

  2014cites this paper
• Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.

  2013cites this paper
• A mouse model of hemolytic disease of the newborn.

  2013cites this paper
• Comment on Stowell et al , page 1494 A mouse model of hemolytic disease of the newborn-----------------------------------------------------------------------------------------------------Chance

  2013cites this paper
• Precision ‘re’arming of CD33 antibodies A mouse model of hemolytic disease of the newborn

  2013cites this paper
• Precision 're'arming of CD33 antibodies.

  2013cites this paper
• A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation.

  2013cites this paper